UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 117

Sortiert nach

A pilot program of HIV pre-exposure prophylaxis in Thai youth

PloS one, 2024-02, Vol.19 (2), p.e0298914-e0298914

2024

Volltextzugriff (PDF)

Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study

PLoS medicine, 2022-09, Vol.19 (9), p.e1004097-e1004097

2022

Volltextzugriff (PDF)

Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries

Nature communications, 2024-05, Vol.15 (1), p.3947-3947, Article 3947

2024

Volltextzugriff (PDF)

Role of efavirenz plasma concentrations on long-term HIV suppression and immune restoration in HIV-infected children

PloS one, 2019-05, Vol.14 (5), p.e0216868-e0216868

2019

Volltextzugriff (PDF)

Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate

International journal of infectious diseases, 2020-08, Vol.97, p.365-370

2020

Volltextzugriff (PDF)

Pilot evaluation of an enzymatic assay for rapid measurement of antiretroviral drug concentrations

Virology journal, 2021-04, Vol.18 (1), p.77-77, Article 77

2021

Volltextzugriff (PDF)

A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study

BMC infectious diseases, 2017-07, Vol.17 (1), p.496-496, Article 496

2017

Volltextzugriff (PDF)

Borrowing information across patient subgroups in clinical trials, with application to a paediatric trial

BMC medical research methodology, 2022-02, Vol.22 (1), p.49-49, Article 49

2022

Volltextzugriff (PDF)

Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1

Infectious diseases and therapy, 2024-08, Vol.13 (8), p.1877-1891

2024

Volltextzugriff (PDF)

Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes

BMJ open, 2021-10, Vol.11 (10), p.e050116-e050116

2021

Volltextzugriff (PDF)

Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015

Viruses, 2021-07, Vol.13 (8), p.1423

2021

Volltextzugriff (PDF)

A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial

JMIR mHealth and uHealth, 2022-04, Vol.10 (4), p.e25561-e25561

2022

Volltextzugriff (PDF)

Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

PloS one, 2015-05, Vol.10 (5), p.e0126647

2015

Volltextzugriff (PDF)

Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B

The New England journal of medicine, 2018-03, Vol.378 (10), p.911-923

2018

Volltextzugriff (PDF)

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

The New England journal of medicine, 2021-12, Vol.385 (27), p.2531-2543

2021

Volltextzugriff (PDF)

Expanding options of child-friendly, single-tablet regimens for young children with HIV

The lancet HIV, 2024-05, Vol.11 (5), p.e275-e276

2024

Volltextzugriff (PDF)

Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

PloS one, 2015-06, Vol.10 (6), p.e0130917-e0130917

2015

Volltextzugriff (PDF)

Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

PloS one, 2015-08, Vol.10 (8), p.e0137368-e0137368

2015

Volltextzugriff (PDF)

Nevirapine Exposure with WHO Pediatric Weight Band Dosing: Enhanced Therapeutic Concentrations Predicted Based on Extensive International Pharmacokinetic Experience

Antimicrobial Agents and Chemotherapy, 2012-10, Vol.56 (10), p.5374-5380

2012

Volltextzugriff (PDF)

Semi-quantification of HIV-1 protease inhibitor concentrations in clinical samples of HIV-infected patients using a gold nanoparticle-based immunochromatographic assay

Analytica chimica acta, 2019-09, Vol.1071, p.86-97

2019

Volltextzugriff (PDF)

Single Dose Abacavir Pharmacokinetics and Safety in Neonates Exposed to Human Immunodeficiency Virus (HIV)

Clinical infectious diseases, 2021-06, Vol.72 (11), p.2032-2034

2021

Volltextzugriff (PDF)

Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings

AIDS (London), 2020-02, Vol.34 (2), p.255-260

2020

Volltextzugriff (PDF)

Urine Tenofovir Concentrations Correlate With Plasma and Relate to Tenofovir Disoproxil Fumarate Adherence: A Randomized, Directly Observed Pharmacokinetic Trial (TARGET Study)

Clinical infectious diseases, 2020-05, Vol.70 (10), p.2143-2151

2020

Volltextzugriff (PDF)

Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV

Clinical pharmacokinetics, 2020-10, Vol.59 (10), p.1185-1194

2020

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Zeitschrift / SerieJournal Of Antimicrobial Chemotherapy

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)

Publikationsform

Artikel
(117)

Sprache

Englisch
(117)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A pilot program of HIV pre-exposure prophylaxis in Thai youth

Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study

Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries

Role of efavirenz plasma concentrations on long-term HIV suppression and immune restoration in HIV-infected children

Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate

Pilot evaluation of an enzymatic assay for rapid measurement of antiretroviral drug concentrations

A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study

Borrowing information across patient subgroups in clinical trials, with application to a paediatric trial

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial

Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1

Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes

Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015

A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial

Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

Expanding options of child-friendly, single-tablet regimens for young children with HIV

Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

Nevirapine Exposure with WHO Pediatric Weight Band Dosing: Enhanced Therapeutic Concentrations Predicted Based on Extensive International Pharmacokinetic Experience

Semi-quantification of HIV-1 protease inhibitor concentrations in clinical samples of HIV-infected patients using a gold nanoparticle-based immunochromatographic assay

Single Dose Abacavir Pharmacokinetics and Safety in Neonates Exposed to Human Immunodeficiency Virus (HIV)

Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings

Urine Tenofovir Concentrations Correlate With Plasma and Relate to Tenofovir Disoproxil Fumarate Adherence: A Randomized, Directly Observed Pharmacokinetic Trial (TARGET Study)

Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV

Aktive Filter

Suchergebnisse filtern